Cargando…
A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV non-small cell lung cancer
BACKGROUND: This study was designed to investigate the impact of age on the effectiveness and immune-related adverse events (irAEs) of programmed death-(ligand)1 [PD-(L)1] inhibitors in patients with non-small cell lung cancer (NSCLC) using a novel text-mining technique. METHODS: This retrospective...
Autores principales: | Abedian Kalkhoran, Hanieh, Zwaveling, Juliëtte, Storm, Bert N., van Laar, Sylvia A., Portielje, Johanneke EA, Codrington, Henk, Luijten, Dieuwke, Brocken, Pepijn, Smit, Egbert F., Visser, Loes E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015929/ https://www.ncbi.nlm.nih.gov/pubmed/36918817 http://dx.doi.org/10.1186/s12885-023-10701-z |
Ejemplares similares
-
An Electronic Health Record Text Mining Tool to Collect Real‐World Drug Treatment Outcomes: A Validation Study in Patients With Metastatic Renal Cell Carcinoma
por: van Laar, Sylvia A., et al.
Publicado: (2020) -
Application of Electronic Health Record Text Mining: Real-World Tolerability, Safety, and Efficacy of Adjuvant Melanoma Treatments
por: van Laar, Sylvia A., et al.
Publicado: (2022) -
Evaluation and Implementation of ListeningTime: A Web-Based Preparatory Communication Tool for Elderly Patients With Cancer and Their Health Care Providers
por: Noordman, Janneke, et al.
Publicado: (2019) -
Association of tumour and stroma PD-1, PD-L1, CD3, CD4 and CD8 expression with DCB and OS to nivolumab treatment in NSCLC patients pre-treated with chemotherapy
por: Niemeijer, Anna-Larissa Nadia, et al.
Publicado: (2020) -
Pd on cyclotriphosphazen-hexa imine decorated boehmite as an efficient catalyst for hydrogenation of nitro arenes under mild reaction condition
por: Sadjadi, Samahe, et al.
Publicado: (2022)